12-2679712-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000719.7(CACNA1C):​c.5360C>T​(p.Thr1787Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000645 in 1,610,588 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T1787T) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0033 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00036 ( 1 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

4
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.83

Publications

8 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006759852).
BP6
Variant 12-2679712-C-T is Benign according to our data. Variant chr12-2679712-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136635.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00335 (510/152346) while in subpopulation AFR AF = 0.0116 (483/41588). AF 95% confidence interval is 0.0108. There are 2 homozygotes in GnomAd4. There are 245 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 510 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.5594C>T p.Thr1865Met missense_variant Exon 44 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.5327C>T p.Thr1776Met missense_variant Exon 41 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.5525C>T p.Thr1842Met missense_variant Exon 43 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.5504C>T p.Thr1835Met missense_variant Exon 44 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.5483C>T p.Thr1828Met missense_variant Exon 42 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.5450C>T p.Thr1817Met missense_variant Exon 42 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.5450C>T p.Thr1817Met missense_variant Exon 42 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.5450C>T p.Thr1817Met missense_variant Exon 42 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.5450C>T p.Thr1817Met missense_variant Exon 42 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.5444C>T p.Thr1815Met missense_variant Exon 43 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.5435C>T p.Thr1812Met missense_variant Exon 43 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.5420C>T p.Thr1807Met missense_variant Exon 43 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.5417C>T p.Thr1806Met missense_variant Exon 42 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.5417C>T p.Thr1806Met missense_variant Exon 42 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.5417C>T p.Thr1806Met missense_variant Exon 42 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.5411C>T p.Thr1804Met missense_variant Exon 42 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.5402C>T p.Thr1801Met missense_variant Exon 42 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.5384C>T p.Thr1795Met missense_variant Exon 41 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.5384C>T p.Thr1795Met missense_variant Exon 41 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.5378C>T p.Thr1793Met missense_variant Exon 41 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.5360C>T p.Thr1787Met missense_variant Exon 42 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.5351C>T p.Thr1784Met missense_variant Exon 42 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.5327C>T p.Thr1776Met missense_variant Exon 41 of 46 ENSP00000507309.1

Frequencies

GnomAD3 genomes
AF:
0.00334
AC:
508
AN:
152228
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000916
AC:
219
AN:
239144
AF XY:
0.000707
show subpopulations
Gnomad AFR exome
AF:
0.0131
Gnomad AMR exome
AF:
0.000828
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000561
Gnomad OTH exome
AF:
0.000339
GnomAD4 exome
AF:
0.000363
AC:
529
AN:
1458242
Hom.:
1
Cov.:
32
AF XY:
0.000316
AC XY:
229
AN XY:
725132
show subpopulations
African (AFR)
AF:
0.0109
AC:
362
AN:
33352
American (AMR)
AF:
0.000882
AC:
39
AN:
44238
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25990
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39572
South Asian (SAS)
AF:
0.0000584
AC:
5
AN:
85662
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53048
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000576
AC:
64
AN:
1110378
Other (OTH)
AF:
0.000863
AC:
52
AN:
60238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
33
65
98
130
163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00335
AC:
510
AN:
152346
Hom.:
2
Cov.:
33
AF XY:
0.00329
AC XY:
245
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0116
AC:
483
AN:
41588
American (AMR)
AF:
0.00105
AC:
16
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68026
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00172
Hom.:
2
Bravo
AF:
0.00365
ESP6500AA
AF:
0.0106
AC:
43
ESP6500EA
AF:
0.000239
AC:
2
ExAC
AF:
0.00116
AC:
140
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 07, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Sep 07, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The CACNA1C c.5360C>T (p.Thr1787Met) variant involves the alteration of a conserved nucleotide. 3/5 in silico tools predict a benign outcome for this variant. This variant was found in 126/107256 control chromosomes (one homozygote), predominantly observed in the African subpopulation at a frequency of 0.0161245 (115/7132). This frequency is about 1612 times the estimated maximal expected allele frequency of a pathogenic CACNA1C variant (0.00001), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. This variant has been reported in three patients with arrhythmia in literature (Burashnikov_2010, Steffensen_2015, Wemhoner_2015), however without evidence for pathogenicity. One of the patients also carried a truncating variant in other gene, AKAP9 p.Thr3473AsnfsX3. Multiple clinical diagnostic laboratories have classified this variant as benign. Taken together, this variant is classified as Benign.

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Brugada syndrome Benign:1
Dec 24, 2018
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Long QT syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
Jul 11, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.012
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;T
Eigen
Benign
-0.12
Eigen_PC
Benign
-0.23
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.0
.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
MetaRNN
Benign
0.0068
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Benign
0.0
.;.;.;.;.;.;.;.;.;.;L;.;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
2.8
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.5
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;.
REVEL
Uncertain
0.34
Sift
Benign
0.050
D;T;T;D;T;T;D;D;D;D;T;T;T;D;T;D;D;D;D;D;T;D;.
Sift4G
Benign
0.10
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Vest4
0.23
ClinPred
0.013
T
GERP RS
1.8
gMVP
0.39
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs192749597; hg19: chr12-2788878; API